IGFBP3 was associated with prognosis of patients with GC, and inhibited proliferation, migration as well as invasion of GC cells by suppressing the NF-κB activity, and inactivating metalloproteinase 14 (MMP14) and urokinase-type plasminogen activator (uPA)29,30. Here, NFKB1 is linked to gastric cancer.